Advanced search
Publication Cover
Leukemia & Lymphoma Volume 54, 2013 - Issue 4
Submit an article Journal homepage
257
Views
11
CrossRef citations to date
0
Altmetric
Letter

Quantitative detection of IDH2 mutation for minimal residual disease monitoring in patients with acute myeloid leukemia and its comparison with mutations in NPM1 gene

Ivana JeziskovaDepartment of Internal Medicine – Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic
,
Filip RazgaDepartment of Internal Medicine – Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic
,
Martina ToskovaDepartment of Internal Medicine – Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic
,
Dana DvorakovaDepartment of Internal Medicine – Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic;CEITEC – Central European Institute of Technology, Masaryk University, Brno, Czech Republic
,
Shira TimilsinaDepartment of Internal Medicine – Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic
,
Jiri MayerDepartment of Internal Medicine – Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic;CEITEC – Central European Institute of Technology, Masaryk University, Brno, Czech Republic
&
Zdenek RacilDepartment of Internal Medicine – Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic;CEITEC – Central European Institute of Technology, Masaryk University, Brno, Czech RepublicCorrespondence[email protected]
 show all
Pages 867-870 | Received 21 Jun 2012, Accepted 01 Sep 2012, Published online: 28 Sep 2012

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Tingyu Yu, Jianxiang Chi & Li Wang. (2021) Clinical values of gene alterations as marker of minimal residual disease in non-M3 acute myeloid leukemia. Hematology 26:1, pages 848-859.
Read now
Giacomo Andreani & Daniela Cilloni. (2019) Strategies for minimal residual disease detection: current perspectives. Blood and Lymphatic Cancer: Targets and Therapy 9, pages 1-8.
Read now
Evgenii Shumilov, Johanna Flach, Raphael Joncourt, Naomi Porret, Gertrud Wiedemann, Urban Novak, Eva Gfeller, Barbara Jeker, Ursula Amstutz, Thomas Pabst & Ulrike Bacher. (2019) Clinical value of molecular MRD monitoring by next-generation sequencing in patients with IDH2 mutated AML. Leukemia & Lymphoma 60:10, pages 2588-2590.
Read now
Benjamin Tomlinson & Hillard M. Lazarus. (2017) Enhancing acute myeloid leukemia therapy - monitoring response using residual disease testing as a guide to therapeutic decision-making. Expert Review of Hematology 10:6, pages 563-574.
Read now

Articles from other publishers (7)

Alexandra Teixeira, Luís Carreira, Sara Abalde-Cela, Belém Sampaio-Marques, Anabela C. Areias, Paula Ludovico & Lorena Diéguez. (2023) Current and Emerging Techniques for Diagnosis and MRD Detection in AML: A Comprehensive Narrative Review. Cancers 15:5, pages 1362.
Crossref
Hsiao-Wen Kao, Ming-Chung Kuo, Ying-Jung Huang, Hung Chang, Shu-Fen Hu, Chein-Fuang Huang, Yu-Shin Hung, Tung-Liang Lin, Che-Wei Ou, Ming-Yu Lien, Jin-Hou Wu, Chih-Cheng Chen & Lee-Yung Shih. (2022) Measurable Residual Disease Monitoring by Locked Nucleic Acid Quantitative Real-Time PCR Assay for IDH1/2 Mutation in Adult AML. Cancers 14:24, pages 6205.
Crossref
Daniela Cilloni, Jessica Petiti, Valentina Rosso, Giacomo Andreani, Matteo Dragani, Carmen Fava & Giuseppe Saglio. (2019) Digital PCR in Myeloid Malignancies: Ready to Replace Quantitative PCR?. International Journal of Molecular Sciences 20:9, pages 2249.
Crossref
Fabio Forghieri, Patrizia Comoli, Roberto Marasca, Leonardo Potenza & Mario Luppi. (2018) Minimal/Measurable Residual Disease Monitoring in NPM1-Mutated Acute Myeloid Leukemia: A Clinical Viewpoint and Perspectives. International Journal of Molecular Sciences 19:11, pages 3492.
Crossref
Lucie Petrova, Filip Vrbacky, Miriam Lanska, Alzbeta Zavrelova, Pavel Zak & Katerina Hrochova. (2018) IDH1 and IDH2 mutations in patients with acute myeloid leukemia: Suitable targets for minimal residual disease monitoring?. Clinical Biochemistry 61, pages 34-39.
Crossref
Andrew Hantel, Wendy Stock & Satyajit Kosuri. (2018) Molecular Minimal Residual Disease Testing in Acute Myeloid Leukemia: A Review for the Practicing Clinician. Clinical Lymphoma Myeloma and Leukemia 18:10, pages 636-647.
Crossref
Velizar Shivarov, Milena Ivanova, Evgueniy Hadjiev & Elissaveta Naumova. (2013) Novel Multiplex Bead-Based Assay for Detection of IDH1 and IDH2 Mutations in Myeloid Malignancies. PLoS ONE 8:9, pages e76944.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.